Machine learning solutions in radiology: does the emperor have no clothes?
Authors:
- 15 April 2021
- journal article
- editorial
- Published by Springer Nature in European Radiology
- Vol. 31 (6) , 3783-3785
Abstract
Key Points • Interest in radiomics and machine learning is steadily increasing and is reflected both in research output and number of commercially available solutions. • Currently available commercial products using machine learning are often supported by limited evidence of clinical usefulness and studies are often of low methodological quality. • Ethical and regulatory issues remain open and hinder implementation of machine learning software packages in daily clinical practice.Keywords
This publication has 9 references indexed in Scilit:
- Artificial intelligence in radiology: 100 commercially available products and their scientific evidenceEuropean Radiology, 2021
- To buy or not to buy—evaluating commercial AI solutions in radiology (the ECLAIR guidelines)European Radiology, 2021
- Bringing AI to the clinic: blueprint for a vendor-neutral AI deployment infrastructureInsights into Imaging, 2021
- The ethical questions that haunt facial-recognition researchNature, 2020
- Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectivesEuropean Radiology, 2020
- A decade of radiomics research: are images really data or just patterns in the noise?European Radiology, 2020
- Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma—a systematic review and meta-analysisEuropean Radiology, 2020
- Ethical and legal challenges of artificial intelligence-driven healthcare2020
- App law within: rights and regulation in the smartphone ageInternational Journal of Law and Information Technology, 2013